Research ArticleArticle
Near-infrared Fluorescence Optical Imaging in Early Rheumatoid Arthritis: A Comparison to Magnetic Resonance Imaging and Ultrasonography
Michaela Krohn, Sarah Ohrndorf, Stephanie G. Werner, Bernd Schicke, Gerd-Rüdiger Burmester, Bernd Hamm, Marina Backhaus and Kay-Geert A. Hermann
The Journal of Rheumatology May 2015, jrheum.141244; DOI: https://doi.org/10.3899/jrheum.141244
Michaela Krohn
From the Department of Radiology, and the Department of Rheumatology and Clinical Immunology, Charité University Hospital, Berlin; RHIO – Rheumatology, Immunology, Osteology Center, Düsseldorf; Berlin Cancer Center (Tumorzentrum Berlin), Berlin, Germany. The Department of Rheumatology and Clinical Immunology, Charité University Hospital, Berlin, Germany, was supported by a research grant from Pfizer to perform the Xiralite imaging system examinations and analyses for this study. Dr. Hermann received lecture fees from Pfizer. M. Krohn, MD, Department of Radiology, Charité University Hospital; S. Ohrndorf, MD, Department of Rheumatology and Clinical Immunology, Charité University Hospital; S.G. Werner, MD, RHIO; B. Schicke, Berlin Cancer Center (Tumorzentrum Berlin); G.R. Burmester, MD, PhD, Department of Rheumatology and Clinical Immunology, Charité University Hospital; B. Hamm, MD, PhD, Department of Radiology, Charité University Hospital; M. Backhaus, MD, PhD, Department of Rheumatology and Clinical Immunology, Charité University Hospital; K.G. Hermann, MD, PhD, Department of Radiology, Charité University Hospital. Address correspondence to Dr. K.G. Hermann, Charité University Hospital, Institute of Radiology, Charitéplatz 1, 10117 Berlin, Germany. E-mail: kghermann@gmail.com. Accepted for publication March 2, 2015.
Sarah Ohrndorf
From the Department of Radiology, and the Department of Rheumatology and Clinical Immunology, Charité University Hospital, Berlin; RHIO – Rheumatology, Immunology, Osteology Center, Düsseldorf; Berlin Cancer Center (Tumorzentrum Berlin), Berlin, Germany. The Department of Rheumatology and Clinical Immunology, Charité University Hospital, Berlin, Germany, was supported by a research grant from Pfizer to perform the Xiralite imaging system examinations and analyses for this study. Dr. Hermann received lecture fees from Pfizer. M. Krohn, MD, Department of Radiology, Charité University Hospital; S. Ohrndorf, MD, Department of Rheumatology and Clinical Immunology, Charité University Hospital; S.G. Werner, MD, RHIO; B. Schicke, Berlin Cancer Center (Tumorzentrum Berlin); G.R. Burmester, MD, PhD, Department of Rheumatology and Clinical Immunology, Charité University Hospital; B. Hamm, MD, PhD, Department of Radiology, Charité University Hospital; M. Backhaus, MD, PhD, Department of Rheumatology and Clinical Immunology, Charité University Hospital; K.G. Hermann, MD, PhD, Department of Radiology, Charité University Hospital. Address correspondence to Dr. K.G. Hermann, Charité University Hospital, Institute of Radiology, Charitéplatz 1, 10117 Berlin, Germany. E-mail: kghermann@gmail.com. Accepted for publication March 2, 2015.
Stephanie G. Werner
From the Department of Radiology, and the Department of Rheumatology and Clinical Immunology, Charité University Hospital, Berlin; RHIO – Rheumatology, Immunology, Osteology Center, Düsseldorf; Berlin Cancer Center (Tumorzentrum Berlin), Berlin, Germany. The Department of Rheumatology and Clinical Immunology, Charité University Hospital, Berlin, Germany, was supported by a research grant from Pfizer to perform the Xiralite imaging system examinations and analyses for this study. Dr. Hermann received lecture fees from Pfizer. M. Krohn, MD, Department of Radiology, Charité University Hospital; S. Ohrndorf, MD, Department of Rheumatology and Clinical Immunology, Charité University Hospital; S.G. Werner, MD, RHIO; B. Schicke, Berlin Cancer Center (Tumorzentrum Berlin); G.R. Burmester, MD, PhD, Department of Rheumatology and Clinical Immunology, Charité University Hospital; B. Hamm, MD, PhD, Department of Radiology, Charité University Hospital; M. Backhaus, MD, PhD, Department of Rheumatology and Clinical Immunology, Charité University Hospital; K.G. Hermann, MD, PhD, Department of Radiology, Charité University Hospital. Address correspondence to Dr. K.G. Hermann, Charité University Hospital, Institute of Radiology, Charitéplatz 1, 10117 Berlin, Germany. E-mail: kghermann@gmail.com. Accepted for publication March 2, 2015.
Bernd Schicke
From the Department of Radiology, and the Department of Rheumatology and Clinical Immunology, Charité University Hospital, Berlin; RHIO – Rheumatology, Immunology, Osteology Center, Düsseldorf; Berlin Cancer Center (Tumorzentrum Berlin), Berlin, Germany. The Department of Rheumatology and Clinical Immunology, Charité University Hospital, Berlin, Germany, was supported by a research grant from Pfizer to perform the Xiralite imaging system examinations and analyses for this study. Dr. Hermann received lecture fees from Pfizer. M. Krohn, MD, Department of Radiology, Charité University Hospital; S. Ohrndorf, MD, Department of Rheumatology and Clinical Immunology, Charité University Hospital; S.G. Werner, MD, RHIO; B. Schicke, Berlin Cancer Center (Tumorzentrum Berlin); G.R. Burmester, MD, PhD, Department of Rheumatology and Clinical Immunology, Charité University Hospital; B. Hamm, MD, PhD, Department of Radiology, Charité University Hospital; M. Backhaus, MD, PhD, Department of Rheumatology and Clinical Immunology, Charité University Hospital; K.G. Hermann, MD, PhD, Department of Radiology, Charité University Hospital. Address correspondence to Dr. K.G. Hermann, Charité University Hospital, Institute of Radiology, Charitéplatz 1, 10117 Berlin, Germany. E-mail: kghermann@gmail.com. Accepted for publication March 2, 2015.
Gerd-Rüdiger Burmester
From the Department of Radiology, and the Department of Rheumatology and Clinical Immunology, Charité University Hospital, Berlin; RHIO – Rheumatology, Immunology, Osteology Center, Düsseldorf; Berlin Cancer Center (Tumorzentrum Berlin), Berlin, Germany. The Department of Rheumatology and Clinical Immunology, Charité University Hospital, Berlin, Germany, was supported by a research grant from Pfizer to perform the Xiralite imaging system examinations and analyses for this study. Dr. Hermann received lecture fees from Pfizer. M. Krohn, MD, Department of Radiology, Charité University Hospital; S. Ohrndorf, MD, Department of Rheumatology and Clinical Immunology, Charité University Hospital; S.G. Werner, MD, RHIO; B. Schicke, Berlin Cancer Center (Tumorzentrum Berlin); G.R. Burmester, MD, PhD, Department of Rheumatology and Clinical Immunology, Charité University Hospital; B. Hamm, MD, PhD, Department of Radiology, Charité University Hospital; M. Backhaus, MD, PhD, Department of Rheumatology and Clinical Immunology, Charité University Hospital; K.G. Hermann, MD, PhD, Department of Radiology, Charité University Hospital. Address correspondence to Dr. K.G. Hermann, Charité University Hospital, Institute of Radiology, Charitéplatz 1, 10117 Berlin, Germany. E-mail: kghermann@gmail.com. Accepted for publication March 2, 2015.
Bernd Hamm
From the Department of Radiology, and the Department of Rheumatology and Clinical Immunology, Charité University Hospital, Berlin; RHIO – Rheumatology, Immunology, Osteology Center, Düsseldorf; Berlin Cancer Center (Tumorzentrum Berlin), Berlin, Germany. The Department of Rheumatology and Clinical Immunology, Charité University Hospital, Berlin, Germany, was supported by a research grant from Pfizer to perform the Xiralite imaging system examinations and analyses for this study. Dr. Hermann received lecture fees from Pfizer. M. Krohn, MD, Department of Radiology, Charité University Hospital; S. Ohrndorf, MD, Department of Rheumatology and Clinical Immunology, Charité University Hospital; S.G. Werner, MD, RHIO; B. Schicke, Berlin Cancer Center (Tumorzentrum Berlin); G.R. Burmester, MD, PhD, Department of Rheumatology and Clinical Immunology, Charité University Hospital; B. Hamm, MD, PhD, Department of Radiology, Charité University Hospital; M. Backhaus, MD, PhD, Department of Rheumatology and Clinical Immunology, Charité University Hospital; K.G. Hermann, MD, PhD, Department of Radiology, Charité University Hospital. Address correspondence to Dr. K.G. Hermann, Charité University Hospital, Institute of Radiology, Charitéplatz 1, 10117 Berlin, Germany. E-mail: kghermann@gmail.com. Accepted for publication March 2, 2015.
Marina Backhaus
From the Department of Radiology, and the Department of Rheumatology and Clinical Immunology, Charité University Hospital, Berlin; RHIO – Rheumatology, Immunology, Osteology Center, Düsseldorf; Berlin Cancer Center (Tumorzentrum Berlin), Berlin, Germany. The Department of Rheumatology and Clinical Immunology, Charité University Hospital, Berlin, Germany, was supported by a research grant from Pfizer to perform the Xiralite imaging system examinations and analyses for this study. Dr. Hermann received lecture fees from Pfizer. M. Krohn, MD, Department of Radiology, Charité University Hospital; S. Ohrndorf, MD, Department of Rheumatology and Clinical Immunology, Charité University Hospital; S.G. Werner, MD, RHIO; B. Schicke, Berlin Cancer Center (Tumorzentrum Berlin); G.R. Burmester, MD, PhD, Department of Rheumatology and Clinical Immunology, Charité University Hospital; B. Hamm, MD, PhD, Department of Radiology, Charité University Hospital; M. Backhaus, MD, PhD, Department of Rheumatology and Clinical Immunology, Charité University Hospital; K.G. Hermann, MD, PhD, Department of Radiology, Charité University Hospital. Address correspondence to Dr. K.G. Hermann, Charité University Hospital, Institute of Radiology, Charitéplatz 1, 10117 Berlin, Germany. E-mail: kghermann@gmail.com. Accepted for publication March 2, 2015.
Kay-Geert A. Hermann
From the Department of Radiology, and the Department of Rheumatology and Clinical Immunology, Charité University Hospital, Berlin; RHIO – Rheumatology, Immunology, Osteology Center, Düsseldorf; Berlin Cancer Center (Tumorzentrum Berlin), Berlin, Germany. The Department of Rheumatology and Clinical Immunology, Charité University Hospital, Berlin, Germany, was supported by a research grant from Pfizer to perform the Xiralite imaging system examinations and analyses for this study. Dr. Hermann received lecture fees from Pfizer. M. Krohn, MD, Department of Radiology, Charité University Hospital; S. Ohrndorf, MD, Department of Rheumatology and Clinical Immunology, Charité University Hospital; S.G. Werner, MD, RHIO; B. Schicke, Berlin Cancer Center (Tumorzentrum Berlin); G.R. Burmester, MD, PhD, Department of Rheumatology and Clinical Immunology, Charité University Hospital; B. Hamm, MD, PhD, Department of Radiology, Charité University Hospital; M. Backhaus, MD, PhD, Department of Rheumatology and Clinical Immunology, Charité University Hospital; K.G. Hermann, MD, PhD, Department of Radiology, Charité University Hospital. Address correspondence to Dr. K.G. Hermann, Charité University Hospital, Institute of Radiology, Charitéplatz 1, 10117 Berlin, Germany. E-mail: kghermann@gmail.com. Accepted for publication March 2, 2015.
In this issue
The Journal of Rheumatology
Vol. 51, Issue 4
1 Apr 2024
Near-infrared Fluorescence Optical Imaging in Early Rheumatoid Arthritis: A Comparison to Magnetic Resonance Imaging and Ultrasonography
Michaela Krohn, Sarah Ohrndorf, Stephanie G. Werner, Bernd Schicke, Gerd-Rüdiger Burmester, Bernd Hamm, Marina Backhaus, Kay-Geert A. Hermann
The Journal of Rheumatology May 2015, jrheum.141244; DOI: 10.3899/jrheum.141244
Near-infrared Fluorescence Optical Imaging in Early Rheumatoid Arthritis: A Comparison to Magnetic Resonance Imaging and Ultrasonography
Michaela Krohn, Sarah Ohrndorf, Stephanie G. Werner, Bernd Schicke, Gerd-Rüdiger Burmester, Bernd Hamm, Marina Backhaus, Kay-Geert A. Hermann
The Journal of Rheumatology May 2015, jrheum.141244; DOI: 10.3899/jrheum.141244